KAS
WST icon

Kemnay Advisory Services’s West Pharmaceutical WST Stock Holding History

Kemnay Advisory Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$169K Buy
471
+442
+1,524% +$135K 0.02% 56
2026
Q1 		$7.27K Sell
29
-49
-63% -$12.2K ﹤0.01% 1083
2025
Q4 		$21.5K Buy
+78
New +$21.3K ﹤0.01% 526

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Kemnay Advisory Services's WST Position: Q2 2026 in Review

Kemnay Advisory Services increased its West Pharmaceutical (WST) stake by 1,524% in Q2 2026, buying an estimated $135K and bringing the position to 471 shares worth $169K. The position accounts for 0.02% of the portfolio, ranked #56.

Kemnay Advisory Services first reported a position in WST in Q4 2025 and has held it in 3 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Kemnay Advisory Services held 471 shares of West Pharmaceutical worth $169K as of Q2 2026.
  • Kemnay Advisory Services bought 442 West Pharmaceutical shares in Q2 2026, an estimated $135K.
  • West Pharmaceutical made up 0.02% of Kemnay Advisory Services's portfolio in Q2 2026, its #56 holding.
  • Kemnay Advisory Services first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.